Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| ICON PLC | ICLR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 306.45 | 04:05:41 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 306.45 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 181.92 - 344.77 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 306.45 | USD |
ICON PLC Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 25.28B | 82.50M | - | 8.12B | 612.34M | 7.42 | 41.29 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
ICON News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ICLR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 296.90 | 307.22 | 287.02 | 296.57 | 633,012 | 9.55 | 3.22% |
| 1 Month | 333.01 | 338.98 | 287.02 | 310.04 | 487,722 | -26.56 | -7.98% |
| 3 Months | 262.91 | 344.77 | 254.5999 | 308.22 | 540,850 | 43.54 | 16.56% |
| 6 Months | 224.51 | 344.77 | 222.32 | 283.90 | 535,022 | 81.94 | 36.50% |
| 1 Year | 207.49 | 344.77 | 181.92 | 254.91 | 603,421 | 98.96 | 47.69% |
| 3 Years | 218.35 | 344.77 | 171.43 | 237.71 | 589,130 | 88.10 | 40.35% |
| 5 Years | 135.11 | 344.77 | 104.275 | 220.56 | 469,581 | 171.34 | 126.82% |
ICON Description
| Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland. |
